PURE Bioscience and AFCO Partner in Multi-Year Distribution Agreement
cience, the innovator behind the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, has entered a multi-year distribution agreement with AFCO, a Zep Company. This strategic partnership will enhance the purchase and distribution of SDC products under tailored terms to serve the food and beverage industry.
Strategic Collaboration for Industry Growth
PURE Vice President of Sales Tim Steffensmeier emphasized the partnership’s significance:
“We are thrilled to partner with AFCO to broaden our distribution network and provide innovative solutions to the food and beverage industry across North America.”
Scott Jimenez, Senior Vice President of AFCO’s West Division, echoed the enthusiasm:
“This collaboration strengthens our ability to offer cutting-edge cleaning and sanitation solutions, ensuring the highest standards of food safety and quality for our clients.”
The Science Behind SDC
SDC’s dual antimicrobial action makes it highly effective. It disrupts microbial membranes and deactivates DNA, preventing replication and leading to rapid microbial death. Unlike traditional silver-based disinfectants, SDC’s stabilized formula offers a longer shelf life, making it a superior solution for sanitation challenges in the food sector.
About the Partners
- AFCO, a Zep Company: Specializes in cleaning and sanitation solutions for the food and beverage industry, leveraging innovation to meet safety and regulatory standards.
- PURE Bioscience, Inc.: Focuses on proprietary antimicrobial technologies, including SDC, to combat pathogens and enhance food safety with reduced toxicity and superior efficacy.
Looking Ahead
The agreement positions PURE and AFCO to lead in delivering safe, sustainable, and effective antimicrobial solutions. With heightened awareness of food safety, this partnership promises to address industry challenges while safeguarding brands and public health.
This press release contains forward-looking statements regarding future performance and plans. These are subject to risks and uncertainties as detailed in PURE’s SEC filings.
